Findings

Intensive blood pressure control does not further reduce the risk of kidney disease progression among nondiabetic patients with kidney disease, concludes a meta-analysis in JAMA Internal Medicine.

In patients with chronic kidney disease (CKD), higher urine potassium excretion—as a surrogate for dietary potassium intake—is associated with a lower risk of death but no difference in the risk of kidney failure, reports a study in American Journal of Kidney Diseases.

Patients who have even relatively small increases in creatinine after starting angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) treatment are at increased risk of adverse cardiorenal events, suggests a study in the British Medical Journal.

For Latino patients with limited English proficiency (LEP), switching to a primary care provider who speaks Spanish is associated with improved control of type 2 diabetes, reports a study in JAMA Internal Medicine.

Added to diet and exercise, once-daily treatment with subcutaneous liraglutide reduces the risk of developing diabetes among obese adults with prediabetes, concludes a trial in The Lancet.

Anticoagulants don’t reduce the risk of stroke in older adults with atrial fibrillation and chronic kidney disease, suggests a study in Kidney International.

Undocumented immigrants with end-stage renal disease (ESRD) suffer from serious physical symptoms and psychosocial distress—particularly related to receiving hemodialysis on an “emergent-only” basis, reports a qualitative study in JAMA Internal Medicine.

The investigators performed semi-structured interviews with 20 undocumented Latino patients with ESRD seen at a safety-net hospital in Colorado. The patients were 10 men and 10 women, mean age 51 years. All had been in the United States for at least 5 years before ESRD diagnosis.

The mineralocorticoid receptor blocker spironolactone does not reduce the risk of acute kidney injury (AKI) in patients undergoing cardiac surgery, concludes a trial in American Journal of Kidney Diseases.

Renal biopsy can be useful in establishing the correct diagnosis and treatment in patients with diabetes—a population with a high prevalence of nondiabetic renal disease (NDRD), according to a meta-analysis in Nephrology Dialysis Transplantation.

The researchers identified and analyzed data on the frequency of diabetic nephropathy, NDRD, and “mixed” forms of kidney disease among patients with diabetes. The analysis included data on 4876 patients undergoing renal biopsy, reported in 48 studies.

Patients with chronic kidney disease (CKD) need a “multimodal, person-centered framework” to support disease self-management, with a special focus on everyday strategies, according to a study in BMC Nephrology.

The cross-sectional survey study solicited Australian CKD patients’ views on their desires for support in self-management of their disease. Thirty-six patients filled out a paper survey at a primary care clinic, and another 61 patients completed an online survey.

Pages